885
Participants
Start Date
July 20, 2015
Primary Completion Date
October 28, 2016
Study Completion Date
October 28, 2016
Smart phone based patient support tool
The smart phone application used on the patients' smart phones will contain both the patient support tool and the questions for the clinical evaluation in the form of the Rosuvastatin Adherence questionnaire (RAQ), Beliefs about Medicine Questionnaire - General (BMQ-G), (Horne, 1999) and a Lifestyle questionnaire (LSQ) on disease understanding, lifestyle and treatment awareness. Patients in the Active group will also receive feedback on their daily rosuvastatin treatment as entered in the patient support tool.
Control application: only for data collection
the patients will have no access to the smart phone-based patient support tool. However, a smart phone application will be used to prompt patients with the questions for the clinical evaluation (RAQ, BMQ-G and LSQ).
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Shanghai
Research Site, Waifang
Research Site, Shandong
Research Site, Tianjin
Research Site, Tianjin
Research Site, Tianjin
Research Site, Hangzhou
Research Site, Huzhou
Research Site, Wenzhou
Research Site, Nanchang
Research Site, Chongqing
Research Site, Changsha
Research Site, Wuhan
Research Site, Chengdu
Lead Sponsor
AstraZeneca
INDUSTRY